
location_on5287, 3500 South, Hunter, West Valley City, Salt Lake County, Utah, 84120, United States
Ratio Therapeutics is committed to improving and extending the lives of cancer patients without sacrificing their quality of life. We are a team of passionate scientists, engineers, and business professionals dedicated to advancing the field of targeted radioligand therapy. To accomplish this, we utilize our proprietary TRILLIUM™ and MACROPA™ platforms: TRILLIUM™ allows fine-tuning of radioligand pharmacokinetics thereby enhancing the therapeutic index, while MACROPA™ simplifies the manufacturing process for the alpha-emitting isotope, actinium-225. These enabling platform technologies have resulted in an emergent pipeline of novel therapeutic candidates. We are looking for talented, dedicated, and creative individuals eager to help us advance these technologies from discovery research through clinical development. Join us in our quest to become the leading innovator in radioligand therapy and improve the lives of cancer patients and their families.
Ratio is seeking an on-site Senior Director of Quality Control (QC) for our Salt Lake City, Utah radiopharmaceutical manufacturing facility. As the Senior Director, QC, you will be the primary architect and hands-on implementer of the analytical and microbiological testing infrastructure for our new state-of-the-art radiopharmaceutical manufacturing facility. During the initial build-out, you will design the systems, workflows, and procedures that will scale with the team. You will be supported by initial analytical and microbiology staff and cross-functional partners, with clear plans to recruit and onboard additional QC personnel as volume increases and day-to-day QC testing demand grows.
Ratio Therapeutics is an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.
Work model: On-site
5287, 3500 South, Hunter, West Valley City, Salt Lake County, Utah, 84120, United States
West Valley City, Utah
Skills: Ich Q2, Usp <1225>, 21 CFR Part §211, 21 CFR §11, HPLC, Gamma Spectrometers, Instant Thin Layer Chromatography, Gas Chromatographs, Waters Empower, Waters Nugenesis LMS.
Education: PhD in Quality Control with 10+ years experience.
Experience developing PET/therapeutic radiopharmaceutical analytical testing methodology
Ratio Therapeutics, headquartered in Boston, Massachusetts, operates as a discovery through early clinical phase pharmaceutical company within the biotechnology research industry. The organization specializes in developing targeted radiotherapeutics designed to treat cancer using a suite of innovative technologies. Its proprietary Trillium targeting scaffold integrates pharmacokinetic modulation with advanced chelation technology to generate small molecule targeting agents capable of addressing a broad array of cancer targets. These compounds are engineered to accommodate both imaging and therapeutic radioisotopes, facilitating a theranostic approach to patient care. The platform's tunable nature, combined with small-scale imaging trials conducted directly in patients, enables accelerated and de-risked compound selection. This methodology supports the company's mission to advance novel treatments for oncology through precision medicine and advanced nuclear medicine capabilities.
Browse more roles: All Ratio Therapeutics jobs, scientific & qa jobs on Recrutus.